| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥30.14B | ¥28.59B | +5.4% |
| Cost of Sales | ¥18.99B | ¥17.51B | +8.5% |
| Gross Profit | ¥11.16B | ¥11.09B | +0.6% |
| SG&A Expenses | ¥6.35B | ¥7.96B | -20.2% |
| Operating Income | ¥4.80B | ¥3.13B | +53.5% |
| Non-operating Income | ¥1.10B | ¥1.04B | +5.7% |
| Non-operating Expenses | ¥169M | ¥142M | +19.0% |
| Ordinary Income | ¥5.74B | ¥4.03B | +42.4% |
| Profit Before Tax | ¥6.99B | ¥3.82B | +83.0% |
| Income Tax Expense | ¥2.07B | ¥1.14B | +82.1% |
| Net Income | ¥4.91B | ¥2.68B | +83.4% |
| Net Income Attributable to Owners | ¥4.87B | ¥2.56B | +90.4% |
| Total Comprehensive Income | ¥6.79B | ¥3.15B | +115.4% |
| Interest Expense | ¥99M | ¥77M | +28.6% |
| Basic EPS | ¥152.38 | ¥77.87 | +95.7% |
| Dividend Per Share | ¥50.00 | ¥50.00 | +0.0% |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥55.85B | ¥58.44B | ¥-2.59B |
| Cash and Deposits | ¥30.42B | ¥30.42B | ¥-1M |
| Accounts Receivable | ¥6.55B | ¥8.57B | ¥-2.03B |
| Inventories | ¥5.82B | ¥5.79B | +¥30M |
| Non-current Assets | ¥85.99B | ¥82.35B | +¥3.64B |
| Item | Value |
|---|---|
| Net Profit Margin | 16.2% |
| Gross Profit Margin | 37.0% |
| Current Ratio | 332.9% |
| Quick Ratio | 298.2% |
| Debt-to-Equity Ratio | 0.52x |
| Interest Coverage Ratio | 48.52x |
| Effective Tax Rate | 29.7% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | +5.4% |
| Operating Income YoY Change | +53.6% |
| Ordinary Income YoY Change | +42.4% |
| Net Income Attributable to Owners YoY Change | +90.4% |
| Total Comprehensive Income YoY Change | +115.4% |
| Item | Value |
|---|---|
| Shares Outstanding (incl. Treasury) | 35.22M shares |
| Treasury Stock | 3.57M shares |
| Average Shares Outstanding | 31.96M shares |
| Book Value Per Share | ¥2,952.58 |
| Item | Amount |
|---|---|
| Year-End Dividend | ¥50.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| Machinery | ¥6.22B | ¥716M |
| Pharmaceuticals | ¥8.41B | ¥819M |
| RealEstate | ¥8.72B | ¥3.45B |
| Textiles | ¥4.84B | ¥497M |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥40.70B |
| Operating Income Forecast | ¥5.00B |
| Ordinary Income Forecast | ¥6.00B |
| Net Income Attributable to Owners Forecast | ¥4.90B |
| Basic EPS Forecast | ¥153.65 |
| Dividend Per Share Forecast | ¥60.00 |
| Property, Plant & Equipment | ¥40.90B | ¥41.16B | ¥-265M |
| Intangible Assets | ¥518M | ¥566M | ¥-48M |
| Investment Securities | ¥37.01B | ¥32.89B | +¥4.13B |
| Total Assets | ¥141.84B | ¥140.79B | +¥1.05B |
| Current Liabilities | ¥16.78B | ¥20.09B | ¥-3.32B |
| Accounts Payable | ¥4.24B | ¥4.79B | ¥-542M |
| Short-term Loans | ¥2.81B | ¥2.88B | ¥-66M |
| Non-current Liabilities | ¥31.61B | ¥30.96B | +¥655M |
| Long-term Loans | ¥3.43B | ¥4.92B | ¥-1.49B |
| Total Liabilities | ¥48.39B | ¥51.05B | ¥-2.66B |
| Total Equity | ¥93.45B | ¥89.73B | +¥3.72B |
| Capital Stock | ¥1.82B | ¥1.82B | ¥0 |
| Capital Surplus | ¥15.53B | ¥15.00B | +¥531M |
| Retained Earnings | ¥58.41B | ¥55.17B | +¥3.25B |
| Treasury Stock | ¥-5.85B | ¥-4.46B | ¥-1.38B |
| Owners' Equity | ¥90.30B | ¥86.04B | +¥4.26B |
| Working Capital | ¥39.07B | - | - |